Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced its financial results for the second quarter ended June 30, 2013.
Second Quarter and Year to Date 2013 Highlights
•Total revenues of $3.8 million in the second quarter of 2013, an increase of 57% over the same quarter in 2012
•Total revenues of $7.5 million for the six months ended June 30, 2013, an increase of 76% over the same period in 2012
Help employers find you! Check out all the jobs and post your resume.
